Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Grovdal, Michael ; Khan, Rasheed ; Aggerholm, Anni ; Antunovic, Petar ; Astermark, Jan LU ; Bernell, Per ; Engstroem, Lena-Maria ; Kjeldsen, Lars ; Linder, Olle and Nilsson, Lars , et al. (2008) 50th Annual Meeting of the American- Society-of-Hematology In Blood 112(11). p.89-89
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
112
issue
11
pages
89 - 89
publisher
American Society of Hematology
conference name
50th Annual Meeting of the American- Society-of-Hematology
conference dates
2008-12-06 - 2008-12-09
external identifiers
  • wos:000262104700224
ISSN
1528-0020
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)
id
a8c692a4-5969-4faa-95fa-7f25a009b877 (old id 1375337)
date added to LUP
2016-04-01 12:04:54
date last changed
2018-11-21 20:03:35
@misc{a8c692a4-5969-4faa-95fa-7f25a009b877,
  author       = {{Grovdal, Michael and Khan, Rasheed and Aggerholm, Anni and Antunovic, Petar and Astermark, Jan and Bernell, Per and Engstroem, Lena-Maria and Kjeldsen, Lars and Linder, Olle and Nilsson, Lars and Olsson, Anna and Wallvik, Jonas and Tangen, Jon Magnus and Oeberg, Gunnar and Jacobsen, Sten Eirik and Porwit, Anna and Hokland, Peter and Helistrom-Lindberg, Eva}},
  issn         = {{1528-0020}},
  language     = {{eng}},
  note         = {{Conference Abstract}},
  number       = {{11}},
  pages        = {{89--89}},
  publisher    = {{American Society of Hematology}},
  series       = {{Blood}},
  title        = {{Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy}},
  volume       = {{112}},
  year         = {{2008}},
}